Targeting the endothelin axis as a therapeutic strategy for oral cancer metastasis and pain.

The mean threshold change for the monotherapy macitentan and EDNRB gene therapy groups were lower than the control group, but did not reach statistical significance (Fig. 6 ).

also in 111,027 other papers